What top creators are saying about Akero Therapeutics Inc.(AKRO)
Biotechnology company developing treatments for metabolic diseases.
2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Akero Therapeutics Inc. in the last 30 days yet.
Top creators covering Akero Therapeutics Inc. (AKRO)
The 1 sources with the most insights about Akero Therapeutics Inc. on Kazuha.
Latest insights about Akero Therapeutics Inc. (AKRO)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Thursday, October 2, 2025
Mentioned as a past investment that has 'not exactly been a big winner,' serving as a warning about its poor past performance.
Monday, July 14, 2025
Listed as one of the biotech/pharma companies the speaker holds positive views on and/or has positions in.
Thursday, October 2, 2025
Mentioned as a past investment that has 'not exactly been a big winner,' serving as a warning about its poor past performance.
Monday, July 14, 2025
Listed as one of the biotech/pharma companies the speaker holds positive views on and/or has positions in.
Discussed alongside Akero Therapeutics Inc. (AKRO)
Other assets that creators frequently mention in the same content as Akero Therapeutics Inc..
Frequently asked
Which podcasters and creators cover Akero Therapeutics Inc. (AKRO) the most?
The most active sources covering Akero Therapeutics Inc. (AKRO) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Akero Therapeutics Inc. (AKRO) are on Kazuha?
Kazuha has indexed 2 AI-extracted insights about Akero Therapeutics Inc. (AKRO) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Akero Therapeutics Inc. (AKRO)?
Creators covering Akero Therapeutics Inc. (AKRO) most frequently also discuss QUBT, SRPT, ABBV, AAPL, GPCR. See the "Discussed alongside" section above for full asset pages.